These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Multi-cellular transitional organotypic models to investigate liver fibrosis. Orbach SM; Ford AJ; Saverot SE; Rajagopalan P Acta Biomater; 2018 Dec; 82():79-92. PubMed ID: 30316024 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice. Hong JS; Lee DH; Yook YW; Na D; Jang YJ; Kim JH; Lee YS Biosci Biotechnol Biochem; 2017 Jul; 81(7):1348-1355. PubMed ID: 28372490 [TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling. Hyun J; Jung Y World J Gastroenterol; 2016 Aug; 22(29):6652-62. PubMed ID: 27547008 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA function in the profibrogenic interplay upon chronic liver disease. Huang J; Yu X; Fries JW; Zhang L; Odenthal M Int J Mol Sci; 2014 May; 15(6):9360-71. PubMed ID: 24871365 [TBL] [Abstract][Full Text] [Related]
29. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. George J; Tsuchishima M; Tsutsumi M J Mol Med (Berl); 2020 Sep; 98(9):1203-1213. PubMed ID: 32666246 [TBL] [Abstract][Full Text] [Related]
30. miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis. Chen W; Yan X; Yang A; Xu A; Huang T; You H Epigenomics; 2020 Jan; 12(1):53-67. PubMed ID: 31833387 [No Abstract] [Full Text] [Related]
32. Wnt signaling in liver fibrosis: progress, challenges and potential directions. Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368 [TBL] [Abstract][Full Text] [Related]
33. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs. Tian XF; Ji FJ; Zang HL; Cao H PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128 [TBL] [Abstract][Full Text] [Related]
34. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. Zhang CY; Yuan WG; He P; Lei JH; Wang CX World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines. Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772 [TBL] [Abstract][Full Text] [Related]
36. [Hepatic fibrogenesis]. Lee KS Korean J Gastroenterol; 2006 Nov; 48(5):297-305. PubMed ID: 17132917 [TBL] [Abstract][Full Text] [Related]
37. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis. Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis. Wang PW; Wu TH; Lin TY; Chen MH; Yeh CT; Pan TL Cells; 2019 Oct; 8(10):. PubMed ID: 31581522 [TBL] [Abstract][Full Text] [Related]
40. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease. Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]